Home/EnCompass Technologies/Kathleen Calderon
KC

Kathleen Calderon

Senior Director of Clinical

EnCompass Technologies

Therapeutic Areas

EnCompass Technologies Pipeline

DrugIndicationPhase
F2 Cerebral Embolic Protection SystemPrevention of brain injury/stroke during Transcatheter Aortic Valve Replacement (TAVR)Pre-clinical